Summary
Pharmaceutical boom in India has opened up the doors of new clinical trials due to various factors, like new research & treatment avenues, which can be explored best in Indian Clinical Trials due to ease of carrying out Clinical trials in india, which is also giving birth to new CROs.
Analysis
Pharmaceutical Industry is Growing practically Exponentially due to rising Noncommunicable & unmanageable Communicable Diseases in India( A stage of Epidemiological Transition), which demands new research & quality treatment avenues, which is best explored through a clinical trial, for which maximum feasible conditions are present in india because of easily available patient, easier Govt approvals, Participation of Private practitioners. All these factors make India A very Good Clinical Trial destination. Most Pharma Companies in India realize the importance of Emerging Clinical Research Organizations( CRO) for its quality clinical trials outcome.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
